THE US Food and Drug Administration (FDA) has advised of warning letters sent to five companies which make products labelled as homeopathic, for "significant violations of current good manufacturing practice (CMP) regulations".
Four of the letters related to companies which jointly produced a homeopathic product called Puriton Eye Relief Drops which posed a significant safety risk to consumers, because the purportedly sterile items were not shown to be sterile in testing of multiple samples by the FDA.
An FDA spokesperson said products labelled as homeopathic were often marketed as natural safe alternatives to approved prescription and non-prescription products, but "may cause significant and even irreparable harm if they are poortly manufactured, which can lead to contamination, or may contain active ingredients that are not adequately tested or disclosed to patients".
The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 19
